Fiber-based laxatives associated with decreased risk for developing colorectal cancer
the ONA take:
According to a new study published in The American Journal of Gastroenterology, researchers at Fred Hutchinson Cancer Research Center in Seattle, Washington, have found that the particular type of laxative a person uses may be associated with varying risks for developing colon cancer.
The researchers found that fiber-containing laxatives are linked with a lower risk for developing colon cancer, compared with non-fiber laxatives are associated with an increased risk for developing the disease.
For the study, researchers analyzed data from over 75,000 adults aged 50 to 76 from western Washington. They found that adults who took fiber-containing laxatives at least 4 days a week for 4 years were 56% less likely to develop colorectal cancer compared with people who did not use laxatives. On the other hand, people who took non-fiber laxatives at least five times a year had nearly a 50% increased risk for developing colorectal cancer compared with those who did not use them.
The researchers suggest that fiber-based laxatives may provide a similar benefit to that of dietary fiber by promoting healthy bacteria growth and diluting amounts of carcinogenic agents in the stool.
Type of laxative a person uses may be associated with varying risks for developing colon cancer.
A new study suggests that the type of laxative a person takes might be a factor in their odds for colon cancer. The research indicates that fiber-based laxatives are associated with a lower risk of colorectal cancer, while non-fiber laxatives are linked with a higher risk. The study could only show an association between laxative types and colon cancer risk, it could not prove cause-and-effect, and experts stress that more study is needed.
Still, the researchers believe the findings are important because about 20 percent of Americans use laxatives.
Sign Up for Free e-newsletters
- Scalp Cooling With Dignicap May Reduce Alopecia During Chemotherapy for Breast Cancer
- Evolution of HER2-Positive Breast Cancer: Yesterday, Today, and Tomorrow
- Dedicated End-of-Life Education Program Improves Nurses' Care, Patient and Family Satisfaction
- Reflexology, Aromatherapy May Reduce Pain, Anxiety of Brachytherapy for Cervical Cancer
- Oncology Extended Care Clinic Reduced Urgent Cancer-Related ED Visits
- Hair Dyes and Cancer Risk (Fact Sheet)
- Taste Changes After Hematopoietic Stem Cell Transplant Affect QOL in Blood Cancers
- Hope, Optimism Reduce Psychological Distress in Advanced Cancer
- Mitomycin Extravasation Protocol
- Accurate Understanding of Capacity May Improve Workflow, Efficiency in Infusion Suite
- Nursing Practice Change Improved Chemo Administration, But Old Habits Die Hard
- Simple Adjustment Key to Paclitaxel Infusion Protocol That Reduced Hypersensitivity Reactions
- Online Program Aims to Assist With Clinical Trial Enrollment for Hematologic Cancers
- Education May Better Equip Nurses to Hold End-of-Life Conversations in Advanced Cancer
- Skipping the SICU Post Head and Neck Cancer Surgery May Improve Outcomes
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|